Essity is a leading global hygiene and health company dedicated to improving well-being through products and solutions. We offer products in wound care, compression therapy, orthopedics and incontinence.
Essity is a global market leader in a number of therapeutic areas. Leukoplast stands for fast and efficient fixation and treatment of surgical and minor wounds. Cutimed is the specialist for the management of chronic and complex wounds. JOBST provides a comprehensive range of product solutions for patients with venous conditions, lymphoedema and lipedema and TENA is our market leading incontinence brand.
Essity supports healthcare professionals with integrated therapy solutions. These form the basis of a holistic approach to treat many medical conditions such as venous leg ulcers, offering both compression garments and wound dressings, to support optimal wound healing.
Our Strategic Vision
To reduce the occurrence of surgical wound complications across the world through advocacy, education, risk identification and improved clinical management.
To reduce the occurrence of surgical wound complications across the world through advocacy, education, risk dentification and improved clinical management.
Increase awareness of causes of SSI & SWD and prevention
Educate the patient and carer
Advance the field of SWD prediction, assessment, prevention and management
Develop evidence based best practice resources for healthcare professionals in the prevention and management of SSI and SWD from global perspective
MiMedx® is a biopharmaceutical company developing, manufacturing and marketing regenerative biologics utilizing human placental allografts for multiple sectors of healthcare. “Innovations in Regenerative Medicine” is the framework behind our mission to provide physicians with products and tissues to help the body heal itself.
At Urgo Medical we pride ourselves on delivering high quality, innovative and sophisticated products. Our wound management dressing range has the unique TLC (Technology Lipido Colloid) that promotes the wound healing matrix and enhanced healing. Our product portfolio comprising of the UrgoStart Plus Treatment Range, UrgoClean Ag, and the UrgoTul range, all providing a treatment option for all wound types. UrgoKTwo is our multicomponent compression bandage system, clinically proven to be as safe and effective as 4-layer. To complete the compression range, Altiform British Standard stockings are designed for post-VLU treatment and Altipress Advanced Leg Ulcer Treatment Hosiery Kit offers a practical and discreet alternative to bandage systems, providing self-care options and saving application time.
The Urgo Medical product range is endorsed by the British Skin Foundation for the extensive clinical research carried out into wound healing and healthy skin.
DEBx Medical B.V. is a Dutch medical technology company dedicated to revolutionizing the management of chronic wounds and persisting infections by enabling their healing, thereby improving the outcomes for millions of patients. DEBx Medical aims to support doctors and their patients from diagnosis through treatment, follow-up care, and maintenance of a healthy wound bed. Our core values focus on delivering affordable, easy-to-use, and implementable treatments in daily clinical practice.
Flen Health believes biotech innovations can help to build a more secure life for all of us. Patients suffering from skin & wound disorders often have to, or will have to give up on activities they enjoy the most. Flen Health want to provide innovation that allows these patients to live the life they love. This is the original, present & future mission
Flen Health was established in 2000, building on the results of wound-treatment research performed by it’s MD, Philippe Sollie, a pharmacist. Based on patented technologies, Flen Health develops and commercialises innovative skin and wound healing solutions.
Thanks to the success on the Belgian market, we initiated international expansion into further affiliates in Luxembourg, the Netherlands, Germany, UK, Ireland, USA and UAE, managed by 100+ motivated employees. Flen Health products are distributed in 30+ countries across the globe.
UK products: Flaminal® Hydro, Flaminal® Forte, Flamigel® RT.
Standing up for legs
The Legs Matter coalition is working together to increase awareness, understanding and action on lower leg and foot conditions among the public and healthcare professionals. We operate under the governance of the Society of Tissue Viability, a registered charity.
Every day, thousands of people’s quality of life is devastated by the lack of support and advice on the prevention of lower leg and foot conditions and the failure to correctly diagnose and treat them. We’re determined to change this.
Non-healing wounds of the leg and foot are one of the biggest health challenges of our time but it is a challenge that can be solved
Everyone has a right to good-quality lower leg and foot care that promotes healing and reduces the risk of harm
We need to improve awareness, understanding and treatment of lower leg and foot conditions
We can achieve more by working together than we can by working alone
We're a member-led charity that uses the power of collaborative thinking and action to solve wound and skin challenges
We are collaborators - We believe that skin health and wound healing is everyone’s business and that change happens when we work together, not in silos.
We are change-makers - We turn ideas into action that changes the way skin health and wound healing is thought about and delivered.
We are crusaders - We are passionate about solving skin and wound challenges and we work to get more people engaged and excited about the possibilities for it.
We are a clean pair of hands - We are led by science and evidence and we never do or endorse anything that we don’t trust or believe in.
Founded in Australia in 2000, WUWHS is the premier wound care professional association and it represents more than 90% of all practicing wound care specialists in the world.
Our members are the wound care-related associations from every part of the world, more than 25.000 emailing contacts. The Association encourages a global approach to education, research and health care delivery to achieve optimal outcomes for patients with acute and chronic wounds.
The Association’s top priority is to raise and maintain the standard of the medical practice of wound care and improve its practice.
The European Pressure Ulcer Advisory Panel (EPUAP) provides a platform for clinicians, researchers, educators, policy makers, industry, and the public to collaboratively work on improved health outcomes for those at risk or suffering from pressure ulcers. EPUAP provides EU wide education and campaigns with accessible resources for clinicians and the public, supporting international and interdisciplinary research activities and partnerships. An important focus is the development of cross continent international clinical guidelines to support practitioners in making informed decisions about interventions for prevention and treatment (visit www.epuap.org/).
The European Pressure Ulcer Advisory Panel (EPUAP) was established in 1997 with the aim to provide relief for persons suffering from, or at risk of, pressure ulcers, through research and education of the public and by influencing pressure ulcer policy in all European countries towards an adequate patient centred and cost-effective pressure ulcer care. Through its conferences, educational events, research funding, networking, patient advocacy, international guideline projects and other activities, EPUAP provides clinicians, scientists, decision makers, industry, and the public with evidence- based perspectives on science, policy, and the potentials, achievements, and the limitations of basic and applied science related to pressure ulcers.
To provide the relief of persons suffering from or at risk of pressure ulcers through: